Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05314868 · ClinicalTrials.gov registry record
Retrospective Evaluation of Photo-oxidized Decellularized Bovine Pericardium in Cardiac Repair or Reconstruction Surgery
A clinical trial, sponsored by Artivion.
- Terminated
- Registry status
- 10
- Enrollment target
NCT05314868: Clinical Trial study, sponsored by Artivion.
NCT05314868 is a clinical trial that was terminated before completion, run by Artivion. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05314868 was terminated before completion, sponsored by Artivion.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The objective of this postmarket, retrospective, single center study is to evaluate the clinical outcomes of patients who have received PhotoFix® Decellularized Bovine Pericardium (PhotoFix) as a patch within a cardiac surgical repair or reconstruction procedure. PhotoFix is prepared from bovine pericardium, which is stabilized using a dye-mediated photo-oxidation process and sterilized using aseptic processing techniques.
Primary Outcome
Mortality
Interventions
- DEVICE PhotoFix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2022-03-31 |
| Est. Completion | 2022-11-30 |
Why NCT05314868 stopped before completion
NCT05314868 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which PhotoFix is the first listed.
NCT05314868 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05314868 about?
NCT05314868 is a clinical study titled "Retrospective Evaluation of Photo-oxidized Decellularized Bovine Pericardium in Cardiac Repair or Reconstruction Surgery". The objective of this postmarket, retrospective, single center study is to evaluate the clinical outcomes of patients who have received PhotoFix® Decellularized Bovine Pericardium (PhotoFix) as a patch within a cardiac surgical repair or reconstruction procedure. PhotoFix is prepared from bovine per...
What is the current status of trial NCT05314868?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2022-03-31. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT05314868?
The interventions under investigation include: PhotoFix (DEVICE).
Who is sponsoring clinical trial NCT05314868?
This trial is sponsored by Artivion, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI